http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9900058-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_807f3706958a3ab857c8ce1b05c9b014 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06 |
filingDate | 1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c43b06dadfc491b3262ec816d62858c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3fb6c4d82c4acaa6889274d699cad44 |
publicationDate | 1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | HU-9900058-A2 |
titleOfInvention | Synthetic multivalent sLEX and procedures for using polylactosamines |
abstract | The invention relates to novel compositions and their use in the treatment of inflammatory responders. More particularly, the present invention relates to novel synthetic oligosaccharide structures, in particular multiple sLex (N-acetyl lactosamines) and their use in the prevention or reduction of lymphocyte attachment to, or reduction of, lymphocyte binding. The invention further relates to the use of such constructs with selectin binding in other disease states, such as bacterial infections and needle throat metastases. The invention further relates to enzymatic processes for the preparation of a novel synthetic glucose saccharide. ŕ |
priorityDate | 1995-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 556.